2 Under-the-Radar Pharma M&A Targets for 2018 Post author:Sam Post published:January 10, 2018 Post category:BioPharma A look at why these two biopharma companies could have targets on their backs. Source: BioSpace You Might Also Like Cancer Biotech Apellis Pharma Sets Terms for $150M IPO October 30, 2017 3 Big Pharmas That Could be Winners for Investors in the Long Run November 29, 2017 FDA's Has Big Plans to Get Drugs Approved Faster, Tackle Drug Development Costs September 11, 2017
